Earnings
BLCM
3.850
-7.67%
-0.320
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
91.03M
0.00
--
303.00K
--
--
0.00
--
--
--
884.00K
19.64M
111.85M
3.57M
--
--
--
--
--
--
825.00K
4.40M
116.25M
--
2.64M
0.00
--
--
--
--
--
10.22M
--
--
--
70.55M
94.42M
25.72M
--
--
--
864.00K
26.58M
121.00M
507.00K
511.68M
-533.02M
-5.06M
--
--
-4.75M
-4.75M
116.25M
FY 2018-12-31
43.70M
49.30M
--
909.00K
--
--
0.00
--
--
--
1.39M
--
95.30M
20.88M
--
0.00
--
--
--
--
5.33M
26.21M
121.50M
--
3.77M
0.00
--
--
--
--
--
8.59M
--
--
--
3.40M
15.80M
35.92M
--
--
--
1.30M
37.22M
53.02M
442.00K
493.78M
-420.55M
-5.06M
--
--
68.48M
68.48M
121.50M
FY 2017-12-31
38.84M
60.06M
--
320.00K
--
--
0.00
--
--
--
2.43M
--
101.65M
25.94M
--
1.37M
--
--
--
--
6.57M
33.88M
135.53M
--
3.29M
0.00
--
--
--
--
--
6.39M
--
--
--
2.45M
12.16M
35.08M
--
--
--
3.65M
38.72M
50.88M
340.00K
411.92M
-322.51M
-5.06M
--
--
84.65M
84.65M
135.53M
FY 2016-12-31
33.14M
70.63M
--
334.00K
--
--
0.00
--
--
--
1.50M
--
105.61M
16.50M
--
0.00
--
--
--
--
9.92M
26.43M
132.04M
--
3.62M
0.00
--
--
--
--
--
9.36M
--
--
--
319.00K
15.11M
18.58M
--
--
--
1.77M
20.35M
35.46M
278.00K
332.07M
-230.73M
-5.06M
--
--
96.57M
96.57M
132.04M
FY 2015-12-31
70.24M
23.82M
--
440.00K
--
--
0.00
--
--
--
2.39M
--
96.89M
6.88M
--
56.30M
--
--
--
--
330.00K
63.52M
160.41M
--
2.11M
0.00
--
--
--
--
--
5.08M
--
--
--
246.00K
7.45M
118.00K
--
--
--
826.00K
944.00K
8.39M
276.00K
318.59M
-302.00K
-5.06M
--
--
152.02M
152.02M
160.41M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BLCM latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Bellicum Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.